Effect of Cranial Manipulation on ANS Activity

NCT ID: NCT02785796

Last Updated: 2017-01-26

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

90 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-05-31

Study Completion Date

2016-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In osteopathy is generally believed that the cranial bones are equipped with an inherent mobility, which like any other joint may face restrictions on movement and then somatic dysfunction. For this reason, different techniques are used with the aim of increasing the mobility of the cranial bones. Some of these have been effective in modifying physiological parameters related to the activity of the autonomic nervous system, such as cardiac function or sleep latency. This study aims to test the effectiveness of a specific craniosacral technique, compression of the fourth ventricle CV4, using the salivary marker alpha amylase, which is sensitive to changes in the activity of the autonomic nervous system. To patients recruited from students of AIMO, we will ask to provide saliva samples before and after CV4 treatment. In particular, saliva will be collected four times per patient: at the initial time, after administration of a stressful event (hand immersion in ice water), immediately after application of the CV4 technique and thirty minutes after the application of the CV4 technique. For each sample of saliva detected, we will proceed to measure the activity of alpha amylase and flow rate, variables sensitive to the activation of the autonomic nervous system.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

A minimum of 90 healthy subjects ranging from 20 to 25 years will be selected from students in Accademia Itliana di Medicina Osteopatica, Saronno, Italy (AIMO) and randomly assigned to the placebo, control or the CV4 arm. Randomization will account for sex and score in the STAI- 2 (form Y) questionnaire, assessing trait anxiety for each subject.

Every sampling session will be taken from 10.00 AM to 1.00 PM to minimize the effect of diurnal variation in salivary alpha-amylase activity. Subjects will be instructed to abstain from eating, smoking, drinking any beverages and exercising 2h before the experiment because these activities has been shown to have an influence on sAA activity.

The day of treatment each subject will completed the STAI-1 (form Y) questionnaire to evaluate the anxiety of the moment. Saliva collection will be made by passive drooling continuously for 5 minutes in a 15 ml falcon tube. Saliva will be collected before, immediately after and 30 minutes after application of a true CV4 technique or application of a sham technique performed by different osteopaths. Saliva samples will be immediately frozen at -20°C for subsequent analysis.

Operators will be osteopaths trained in cranial field. The application of the CV4 and sham protocols will occur in an examination room setting. The subject will lie in supine position with the operator at the head of the treatment table with forearms resting on table either for CV4 either for the sham procedure.

For the CV4 technique the practitioner will contact the participant's occiput (lateral to the external occipital protuberances, but medial to the occipital-mastoid suture) with his or her thenar eminences. When no cranial mobility will be found, operators will be free to use any kind of technique to enhance the cranial movement before CV4 procedure. Once the practitioner will detect the CRI, the practitioner will resist the flexion phase of the CRI and exaggerate the extension phase. This compressive pressure will be maintained until the CRI stopped, and the still-point is reached. The still-point will be held until the CRI return, at which point the compressive pressure will be slowly release. For the sham CV-4, The operator will overlap the hands so that the thumbs formed a "V". The operator's thenar eminences will contact the occiput very lightly well below the positioning used in the CV4 procedure but with no pressure on the occiput between the occipitomastoid sutures. Once placement will be achieved, the operator's hands will remain motionless for 10 min. Finally, the practitioner's hands will be gently removed and the participant's head will be placed on the table for both procedures.

Flow rate will be measured for samples thawed by 5 ml graduated capillary. Samples will be then centrifuged (for ten minutes at 3000 rpm) and the supernatant collect in clean Eppendorf tubes. Salivary alpha-amylase activity will be then measured by a commercial kit (IBL) and a spectrophotometer for the optical reading.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Alpha Amylase Manipulation, Osteopathic

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

CV4

The practitioner will contact the participant's occiput (lateral to the external occipital protuberances, but medial to the occipital-mastoid suture) with his or her thenar eminences. When no cranial mobility will be found, operators will be free to use any kind of technique to enhance the cranial movement before CV4 procedure. Once the practitioner will detect the CRI, the practitioner will resist the flexion phase of the CRI and exaggerate the extension phase. This compressive pressure will be maintained until the CRI stopped, and the still-point is reached. The still-point will be held until the CRI return, at which point the compressive pressure will be slowly release

Group Type EXPERIMENTAL

CV4

Intervention Type OTHER

sham technique

The operator will overlap the hands so that the thumbs formed a "V". The operator's thenar eminences will contact the occiput very lightly well below the positioning used in the CV4 procedure but with no pressure on the occiput between the occipitomastoid sutures. Once placement will be achieved, the operator's hands will remain motionless for 10 min. Finally, the practitioner's hands will be gently removed and the participant's head will be placed on the table for both procedures

Group Type PLACEBO_COMPARATOR

SHAM TECHNIQUE

Intervention Type OTHER

Control

The control group will not receive ant type of treatment: subject just stay quietly in supine position in ambulatory room for ten minutes

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

CV4

Intervention Type OTHER

SHAM TECHNIQUE

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* consensus signed

Exclusion Criteria

* oral contraceptive
* drugs assumption
* pathology of oral cavity
* failure to comply the directives
Minimum Eligible Age

18 Years

Maximum Eligible Age

30 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Accademia Italiana Medicina Osteopatica

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

AIMO

Saronno, Varese, Italy

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Italy

References

Explore related publications, articles, or registry entries linked to this study.

Cutler MJ, Holland BS, Stupski BA, Gamber RG, Smith ML. Cranial manipulation can alter sleep latency and sympathetic nerve activity in humans: a pilot study. J Altern Complement Med. 2005 Feb;11(1):103-8. doi: 10.1089/acm.2005.11.103.

Reference Type BACKGROUND
PMID: 15750368 (View on PubMed)

Nater UM, Rohleder N. Salivary alpha-amylase as a non-invasive biomarker for the sympathetic nervous system: current state of research. Psychoneuroendocrinology. 2009 May;34(4):486-96. doi: 10.1016/j.psyneuen.2009.01.014. Epub 2009 Feb 26.

Reference Type BACKGROUND
PMID: 19249160 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

001

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.